Guest guest Posted September 15, 2011 Report Share Posted September 15, 2011 News 9 new results for hepatitis c Cocrystal Discovery Snags $7.5M in Hepatitis C Collaboration With TevaXconomyCocrystal Discovery, the Bothell, WA-based drug discovery startup led by a couple of Icos veterans, has nailed down $7.5 million in new investment to develop a new kind of hepatitis C drug with Israel-based Teva Pharmaceutical. ...See all stories on this topic » New Hepatitis C Drugs Offer Much-Needed Options but With Added ComplicationsAtlantic Information Services, Inc.By Maas, Managing Editor This year, May brought the FDA approval of two new therapies for chronic hepatitis C genotype 1 infection. Not only are Merck & Co., Inc.'s Victrelis (boceprevir) and Vertex Pharmaceuticals Inc.'s Incivek (telaprevir) ...See all stories on this topic » 10 Hep C Stocks on Wall Street's Watch ListTheStreet.comBy Adam Feuerstein 09/15/11 - 09:05 AM EDT BOSTON (TheStreet) -- It's been a big year for hepatitis C. New drugs from Vertex Pharmaceuticals(VRTX) and Merck(MRK), respectively, were approved and launched commercially that dramatically shorten treatment ...See all stories on this topic » VBI buys Epixis, gains CMV, hep C vaccinesFierceVaccinesVBI also plans to advance Epixis' preclinical hepatitis C vaccine candidate. "Our proof of concept and preclinical findings have been extremely promising in both CMV and Hepatitis C and we believe clearly demonstrate the value of the eVLP platform," ...See all stories on this topic » New hope for hepatitis C vaccinedomain-BHopes for an effective vaccine and treatment against the potentially fatal hepatitis C infection have received a major boost following the discovery of two 'Achilles' heels' within the virus. A team of medical researchers from the University of New ...See all stories on this topic » domain-B Weak Links In Hepatitis C Infection IdentifiedMedIndiaby Gopalan T on September 15, 2011 at 6:40 AM (General Health News) Australian researchers believe they have identified two weak links in hepatitis C infection. The discovery could give a boost to vaccine research, they hope. ...See all stories on this topic » MedIndia Ask the Doctor: What is Hepatitis and HIV co-infection?Westside GazetteHepatitis B and C can cause cirrhosis, cancer and death. A vaccine to prevent hepatitis B exists, and while hepatitis B cannot be cured, it can be treated. No vaccine exists for hepatitis C; however, the treatment can cure it. ...See all stories on this topic » INCIVEK Phase 3 Study Results Published in New England Journal of MedicineThirdAgeResults from a Phase 3 study of the drug INCIVEK (telaprevir), approved by the US Food and Drug Administration (FDA) in May 2011 and Health Canada in August 2011 for the treatment of genotype 1 chronic hepatitis C in adults with compensated liver ...See all stories on this topic » ThirdAge Science magazine names 5 Mass. cos. to 'top employers' listBizjournals.comThe company got its first wholly owned drug approved by the FDA this year, Incivek, to treat Hepatitis C, and the company is in hiring mode, with 150 open positions and a commitment to create 500 jobs by 2015. Millennium: The Takeda Oncology Company ...See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.